TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.

Tonix Pharmaceuticals Holding Corp. Exhibit
EX-99.01 2 s111370_ex99-01.htm EXHIBIT 99.01  Exhibit 99.01   Tonix Pharmaceuticals Receives Fast Track Designation from the U.S. FDA for TNX-102 SL for Treatment of Agitation in Alzheimer’s Disease   NEW YORK,…
To view the full exhibit click here